Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma
Investigative Opthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.2.34 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2024. Verfasst von Yanyan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms, Benzazepines, Pyrimidines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The purpose of this study was to investigate the antitumor effects of GSK-J4 on retinoblastoma, as well as its related biological functions and molecular mechanisms.
Methods
The antitumor effect of GSK-J4 on retinoblastoma was evaluated by in vitro and in vivo assays. CCK-8, EdU incorporation, and soft agar colony formation assays were performed to examine the effect of GSK-J4 on cell proliferation. Flow cytometry was used to evaluate the effect of GSK-J4 on the cell cycle and apoptosis. RNA-seq and Western blotting were conducted to explore the molecular mechanisms of GSK-J4. An orthotopic xenograft model was established to determine the effect of GSK-J4 on tumor growth.
Results
GSK-J4 significantly inhibited retinoblastoma cell proliferation both in vitro and in vivo, arrested the cell cycle at G2/M phase, and induced apoptosis. Mechanistically, GSK-J4 may suppress retinoblastoma cell growth by regulating the PI3K/AKT/NF-κB signaling pathway.
Conclusions
The antitumor effects of GSK-J4 were noticeable in retinoblastoma and were at least partially mediated by PI3K/AKT/NF-κB pathway suppression. Our study provides a novel strategy for the treatment of retinoblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
- Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China.
- Jiangxi Provincial Key Laboratory of Tumor Metastasis and Precision Therapy, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
- Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, PR China.
Zitieren
APA
Zhang, Y., Wu, W., Xu, C., Yang, H., & Huang, G. (2024). Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.2.34
Vancouver
Zhang Y, Wu W, Xu C, Yang H, Huang G. Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.2.34
BibTeX
@article{Zhang2024,
author = {Zhang, Yanyan and Wu, Weiqi and Xu, Caixia and Yang, Hongwei and Huang, Guofu},
title = {Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.2.34}
}
EUVIMED